Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives
We focused on a paper titled “Radiation with immunotherapy may be a double-edged sword—how can we learn from recent negative clinical trials?”, which was published in JAMA Oncology recently. Herein, we initially provided three complementary viewpoints from biological perspectives involved in the dyn...
Saved in:
| Main Authors: | Yanmei Liu, Ganghui Ye, Weijun Chen, Yan Ding, Shenpeng Ying, Shixiu Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1578486/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A non-small cell lung cancer fragile elderly patient treated with immunotherapy and non-ablative radiation therapy: a case report of a winning combination
by: Jessica Saddi, et al.
Published: (2025-08-01) -
Biological sex representation and reporting in stereotactic body radiotherapy for kidney cancer: A review of clinical studies
by: Sylvia Nwokolo, et al.
Published: (2025-11-01) -
Stereotactic body radiation therapy for colorectal liver metastases
by: Issa Mohamad, et al.
Published: (2022-12-01) -
Stereotactic body radiation therapy as initial treatment for head and neck cancer
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
The role of stereotactic radiotherapy in the treatment of the local recurrence of colorectal cancer: A case report
by: Radosavljević Kristina, et al.
Published: (2024-01-01)